J&J CEO: COVID-19 ‘Demonstrated Importance of Self-Care Overall’
Executive Summary
During JP Morgan conference, Alex Gorsky suggests responding to pandemic is changing health care, including businesses providing pharmaceuticals, medical technologies, nutritionals and other necessary products.
You may also be interested in...
Listerine, Tylenol Push J&J Consumer Health To 2020 Finish Line Against Pandemic Weight
Listerine mouthwash drove J&J’s oral care sales up 11.4% in the fourth quarter. Tylenol for adults was the star of its OTC drug business but weakness of children’s Tylenol products and other OTCs led to flat sales.
Balancing Beauty Lineup With International And Regional Brands Factors In J&J Consumer Growth
While J&J benefits from “underlying strength” of its large skin care brands, it targets “regular additions of local, smaller brands,’ says global consumer business head Thibaut Mongon. Portfolio balance of international and localized brands helps it weather economic uncertainty during the COVID-19 pandemic.
Band-Aid Covers Sales Driver Role To Continue J&J’s Consumer Health Business Growth
Iconic brand could have spurred consumer interest and helped drive 15.2% US sales growth for its wound care business with the launch earlier in 2020 of strips in hues that better match the skin tones of black and brown customers.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: